| Value | ₹29.13 Cr |
|---|---|
| Execution period | 18 months |
NSE filing, NSE: ANONDITA. Summary written from the filing by ALFA Finder's alert engine.
Anondita Medicare Ltd: key numbers
- Share price
- ₹1,000.10
- Market cap
- ₹1,905 Cr
- Revenue (annual)
- ₹137.4 Cr
- Net profit (annual)
- ₹33.45 Cr
- P/E (TTM)
- 57.0×Sector 38.3×
- Promoter holding
- 59.26%
- FII holding
- 2.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anondita Medicare Ltd
All →Anondita Medicare Other Announcement
Anondita Medicare Limited has submitted a certificate stating that the compliance report on corporate governance under Regulation 27(2) is not applicable to the company.
Anondita Medicare Annual General Meeting
Anondita Medicare Limited reported the proceedings of its 3rd Annual General Meeting held on September 29, 2026, where several ordinary and special businesses were discussed.
Anondita Medicare Capital Structure Change
Anondita Medicare Limited has reinstated its previous rights issue corrigendum. The issue size is now confirmed at 9,58,166 equity shares, aggregating to ₹91.03 Crore.
- Value
- ₹91.03 Cr
Anondita Medicare Capital Structure Change
Anondita Medicare Limited issued a corrigendum to its Rights Issue, revising the total issue size to ₹91.03 Crore and adjusting the allocation for general corporate purposes.
- Value
- ₹91.03 Cr
Anondita Medicare Other Announcement
Anondita Medicare Limited clarified procedures for handling odd lots of Rights Entitlements and shares during its ongoing Rights Issue. No new transaction value is involved.
Anondita Medicare Annual General Meeting
Anondita Medicare Limited has issued the notice for its 3rd Annual General Meeting scheduled for September 29, 2026. The meeting will address ordinary and special business resolutions.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.